Literature DB >> 29157665

Lipopolysaccharide-Induced Increase in Intestinal Epithelial Tight Permeability Is Mediated by Toll-Like Receptor 4/Myeloid Differentiation Primary Response 88 (MyD88) Activation of Myosin Light Chain Kinase Expression.

Meghali Nighot1, Rana Al-Sadi2, Shuhong Guo2, Manmeet Rawat1, Prashant Nighot2, Martin D Watterson3, Thomas Y Ma4.   

Abstract

Lipopolysaccharides (LPSs) are a major component of the Gram-negative bacterial cell wall and play an important role in mediating intestinal inflammatory responses in inflammatory bowel disease. Although recent studies suggested that physiologically relevant concentrations of LPS (0 to 1 ng/mL) cause an increase in intestinal epithelial tight junction (TJ) permeability, the mechanisms that mediate an LPS-induced increase in intestinal TJ permeability remain unclear. Herein, we show that myosin light chain kinase (MLCK) plays a central role in the LPS-induced increase in TJ permeability. Filter-grown Caco-2 intestinal epithelial monolayers and C57BL/6 mice were used as an in vitro and in vivo intestinal epithelial model system, respectively. LPS caused a dose- and time-dependent increase in MLCK expression and kinase activity in Caco-2 monolayers. The pharmacologic MLCK inhibition and siRNA-induced knock-down of MLCK inhibited the LPS-induced increase in Caco-2 TJ permeability. The LPS increase in TJ permeability was mediated by toll-like receptor 4 (TLR-4)/MyD88 signal-transduction pathway up-regulation of MLCK expression. The LPS-induced increase in mouse intestinal permeability also required an increase in MLCK expression. The LPS-induced increase in intestinal permeability was inhibited in MLCK-/- and TLR-4-/- mice. These data show, for the first time, that the LPS-induced increase in intestinal permeability was mediated by TLR-4/MyD88 signal-transduction pathway up-regulation of MLCK. Therapeutic targeting of these pathways can prevent an LPS-induced increase in intestinal permeability. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29157665      PMCID: PMC5718096          DOI: 10.1016/j.ajpath.2017.08.005

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  55 in total

1.  Introduction for the special issue on "Tissue Barriers in Inflammation".

Authors:  Francis W Luscinskas; Marion Leick; Gail Newton; Asma Nusrat
Journal:  Tissue Barriers       Date:  2015-02-25

2.  Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88.

Authors:  Shuhong Guo; Meghali Nighot; Rana Al-Sadi; Tarik Alhmoud; Prashant Nighot; Thomas Y Ma
Journal:  J Immunol       Date:  2015-10-14       Impact factor: 5.422

Review 3.  Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.

Authors:  L Caradonna; L Amati; T Magrone; N M Pellegrino; E Jirillo; D Caccavo
Journal:  J Endotoxin Res       Date:  2000

4.  Ethanol modulation of intestinal epithelial tight junction barrier.

Authors:  T Y Ma; D Nguyen; V Bui; H Nguyen; N Hoa
Journal:  Am J Physiol       Date:  1999-04

5.  A differentiation-dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability.

Authors:  Daniel R Clayburgh; Shari Rosen; Edwina D Witkowski; Fengjun Wang; Stephanie Blair; Steven Dudek; Joe G N Garcia; John C Alverdy; Jerrold R Turner
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.157

Review 6.  Human endotoxemia as a model of systemic inflammation.

Authors:  A S Andreasen; K S Krabbe; R Krogh-Madsen; S Taudorf; B K Pedersen; K Møller
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

7.  Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.

Authors:  Linda M Feighery; Sean W Cochrane; Teresa Quinn; Alan W Baird; Daniel O'Toole; Sian-Eleri Owens; Diarmuid O'Donoghue; Randall J Mrsny; David J Brayden
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 8.  Signalling pathways in alcohol-induced liver inflammation.

Authors:  Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Hepatol       Date:  2009-03-28       Impact factor: 25.083

9.  Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD?

Authors:  Franco Scaldaferri; Loris Riccardo Lopetuso; Valentina Petito; Valerio Cufino; Mirna Bilotta; Vincenzo Arena; Egidio Stigliano; Giuseppe Maulucci; Massimiliano Papi; Caristo Maria Emiliana; Andrea Poscia; Francesco Franceschi; Giovanni Delogu; Maurizio Sanguinetti; Marco De Spirito; Alessandro Sgambato; Antonio Gasbarrini
Journal:  United European Gastroenterol J       Date:  2014-04       Impact factor: 4.623

10.  Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability.

Authors:  Rana Al-Sadi; Dongmei Ye; Karol Dokladny; Thomas Y Ma
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

View more
  45 in total

1.  Biomaterial-tight junction interaction and potential impacts.

Authors:  Xiangfei Han; Ershuai Zhang; Yuanjie Shi; Boyi Song; Hong Du; Zhiqiang Cao
Journal:  J Mater Chem B       Date:  2019-07-31       Impact factor: 6.331

Review 2.  Making sense of gut feelings in the traumatic brain injury pathogenesis.

Authors:  Luiz Fernando Freire Royes; Fernando Gomez-Pinilla
Journal:  Neurosci Biobehav Rev       Date:  2019-05-16       Impact factor: 8.989

Review 3.  The role of mucosal barriers in human gut health.

Authors:  Kangseok Seo; Jeongmi Seo; Jiyoun Yeun; Haebin Choi; Young-In Kim; Sun-Young Chang
Journal:  Arch Pharm Res       Date:  2021-04-22       Impact factor: 4.946

4.  Lipopolysaccharide-Induced Increase in Intestinal Permeability Is Mediated by TAK-1 Activation of IKK and MLCK/MYLK Gene.

Authors:  Meghali Nighot; Manmeet Rawat; Rana Al-Sadi; Eliseo F Castillo; Prashant Nighot; Thomas Y Ma
Journal:  Am J Pathol       Date:  2019-02-01       Impact factor: 4.307

Review 5.  Epithelial Toll-like receptors and their role in gut homeostasis and disease.

Authors:  Juan F Burgueño; Maria T Abreu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-26       Impact factor: 46.802

6.  SIRT1 relieves Necrotizing Enterocolitis through inactivation of Hypoxia-inducible factor (HIF)-1a.

Authors:  Ming Bai; Chaoxiang Lu; Lu An; Qi Gao; Weike Xie; Feng Miao; Xiaofeng Chen; Yongkang Pan; Qi Wang
Journal:  Cell Cycle       Date:  2020-07-13       Impact factor: 4.534

7.  The scaffolding protein ZO-1 coordinates actomyosin and epithelial apical specializations in vitro and in vivo.

Authors:  Matthew A Odenwald; Wangsun Choi; Wei-Ting Kuo; Gurminder Singh; Anne Sailer; Yitang Wang; Le Shen; Alan S Fanning; Jerrold R Turner
Journal:  J Biol Chem       Date:  2018-09-21       Impact factor: 5.157

8.  Alcohol binge disrupts the rat intestinal barrier: the partial protective role of oleoylethanolamide.

Authors:  M Antón; A Rodríguez-González; A Ballesta; N González; A Del Pozo; F R de Fonseca; M L Gómez-Lus; J C Leza; B García-Bueno; J R Caso; L Orio
Journal:  Br J Pharmacol       Date:  2018-10-29       Impact factor: 8.739

Review 9.  Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity.

Authors:  Yusuke Kinashi; Koji Hase
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

10.  Anterior Gradient Protein 2 Promotes Mucosal Repair in Pediatric Ulcerative Colitis.

Authors:  Xiaolin Ye; Jie Wu; Jing Li; Hongyu Wang
Journal:  Biomed Res Int       Date:  2021-05-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.